Apollo Therapeutics’ $226.5m Series C Financing

Georgio Naffaa Europe Legal Chronicle
Tagged:

Taylor Wessing advised Apollo Therapeutics on its series C funding round.Apollo Therapeutics Limited, a biopharmaceutical company headquartered in Cambridge, has successfully raised $226.5 million in a…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Georgio Naffaa

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here